Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common / Ordinary Stock
-
Total 13F shares
-
679,768
-
Share change
-
-3,996,566
-
Total reported value
-
$29,229,044
-
Price per share
-
$42.97
-
Number of holders
-
15
-
Value change
-
-$169,213,087
-
Number of buys
-
10
-
Number of sells
-
82
Institutional Holders of Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) as of Q2 2024
As of 30 Jun 2024,
Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
679,768 shares.
The largest 10 holders included
Krensavage Asset Management, LLC, Analyst IMS Investment Management Services Ltd., RHUMBLINE ADVISERS, LRI Investments, LLC, Gladius Capital Management LP, OSAIC HOLDINGS, INC., Lindbrook Capital, LLC, Farther Finance Advisors, LLC, MASSMUTUAL TRUST CO FSB/ADV, and CWM, LLC.
This page lists
15
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.